Michael Kauffman Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Michael Kauffman.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Michael Kauffman. Michael Kauffman is Director in INFINITY PHARMACEUTICALS, INC. ($INFI) and Director in EPIRUS Biopharmaceuticals, Inc. ($CRXX) and Chief Executive Officer in Karyopharm Therapeutics Inc. ($KPTI) and Director in Verastem, Inc. ($VSTM) and Director in Kezar Life Sciences, Inc. ($KZR).
Latest Insider Trading Transactions of Michael Kauffman
Sentiment: All, CRXX, INFI, KPTI, KZR, VSTM
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 10 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 12,500 | 413 | 1,764 | |
| Sep 10 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 19.31 | 12,500 | 241,384 | 713,510 | 726 K to 713.5 K (-1.72 %) |
| Sep 10 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 12,500 | 413 | 726,010 | 713.5 K to 726 K (+1.75 %) |
| Aug 21 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 10,000 | 47,520 | 466,061 | |
| Aug 21 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 17.46 | 10,000 | 174,568 | 512,143 | 522.1 K to 512.1 K (-1.92 %) |
| Aug 21 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 10,000 | 47,520 | 522,143 | 512.1 K to 522.1 K (+1.95 %) |
| Aug 08 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 12,500 | 413 | 14,264 | |
| Aug 08 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 18.04 | 12,500 | 225,556 | 713,510 | 726 K to 713.5 K (-1.72 %) |
| Aug 08 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 12,500 | 413 | 726,010 | 713.5 K to 726 K (+1.75 %) |
| Jul 20 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 4,242 | 20,158 | 476,061 | |
| Jul 20 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.26 | 5,757 | 1,520 | 0 | |
| Jul 20 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 1 | 0 | 0 | |
| Jul 20 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 18.27 | 10,000 | 182,686 | 512,143 | 522.1 K to 512.1 K (-1.92 %) |
| Jul 20 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 4,242 | 20,158 | 522,143 | 517.9 K to 522.1 K (+0.82 %) |
| Jul 20 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.26 | 5,757 | 1,520 | 517,901 | 512.1 K to 517.9 K (+1.12 %) |
| Jul 20 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 1 | 0 | 512,144 | 512.1 K to 512.1 K (0.00 %) |
| Jul 10 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 12,500 | 413 | 26,764 | |
| Jul 10 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 18.72 | 12,500 | 233,990 | 713,510 | 726 K to 713.5 K (-1.72 %) |
| Jul 10 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 12,500 | 413 | 726,010 | 713.5 K to 726 K (+1.75 %) |
| Jun 27 2018 | KZR | Kezar Life Science ... | Kauffman Michael | Director | Option Exercise | C | 0.00 | 10,516 | 0 | 0 | |
| Jun 27 2018 | KZR | Kezar Life Science ... | Kauffman Michael | Director | Buy | C | 0.00 | 10,516 | 0 | 63,690 | 53.2 K to 63.7 K (+19.78 %) |
| Jun 27 2018 | KZR | Kezar Life Science ... | Kauffman Michael | Director | Option Exercise | C | 0.00 | 10,516 | 0 | 0 | |
| Jun 27 2018 | KZR | Kezar Life Science ... | Kauffman Michael | Director | Buy | C | 0.00 | 10,516 | 0 | 63,690 | 53.2 K to 63.7 K (+19.78 %) |
| Jun 19 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.26 | 10,000 | 2,640 | 5,757 | |
| Jun 19 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 18.66 | 10,000 | 186,558 | 512,143 | 522.1 K to 512.1 K (-1.92 %) |
| Jun 19 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.26 | 10,000 | 2,640 | 522,143 | 512.1 K to 522.1 K (+1.95 %) |
| Jun 14 2018 | INFI | INFINITY PHARMACEU ... | Kauffman Michael | Director | Option Exercise | A | 1.75 | 20,000 | 35,000 | 20,000 | |
| Jun 11 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 303 | 10 | 7,553 | |
| Jun 11 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.26 | 9,697 | 2,560 | 0 | |
| Jun 11 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 17.30 | 10,000 | 172,991 | 713,510 | 723.5 K to 713.5 K (-1.38 %) |
| Jun 11 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 303 | 10 | 723,510 | 723.2 K to 723.5 K (+0.04 %) |
| Jun 11 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.26 | 9,697 | 2,560 | 723,207 | 713.5 K to 723.2 K (+1.36 %) |
| May 21 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.26 | 10,000 | 2,640 | 15,757 | |
| May 21 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 19.39 | 10,000 | 193,870 | 512,143 | 522.1 K to 512.1 K (-1.92 %) |
| May 21 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.26 | 10,000 | 2,640 | 522,143 | 512.1 K to 522.1 K (+1.95 %) |
| May 08 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.26 | 10,000 | 2,640 | 9,697 | |
| May 08 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 16.77 | 10,000 | 167,747 | 713,510 | 723.5 K to 713.5 K (-1.38 %) |
| May 08 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.26 | 10,000 | 2,640 | 723,510 | 713.5 K to 723.5 K (+1.40 %) |
| Apr 20 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.26 | 7,576 | 2,000 | 18,181 | |
| Apr 20 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.26 | 2,424 | 640 | 0 | |
| Apr 20 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 14.79 | 10,000 | 147,878 | 512,143 | 522.1 K to 512.1 K (-1.92 %) |
| Apr 20 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.26 | 10,000 | 2,640 | 522,143 | 512.1 K to 522.1 K (+1.95 %) |
| Apr 10 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.26 | 10,000 | 2,640 | 19,697 | |
| Apr 10 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 12.48 | 10,000 | 124,829 | 713,510 | 723.5 K to 713.5 K (-1.38 %) |
| Apr 10 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.26 | 10,000 | 2,640 | 723,510 | 713.5 K to 723.5 K (+1.40 %) |
| Mar 20 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.26 | 10,000 | 2,640 | 2,424 | |
| Mar 20 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 15.29 | 10,000 | 152,895 | 512,143 | 522.1 K to 512.1 K (-1.92 %) |
| Mar 20 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.26 | 10,000 | 2,640 | 522,143 | 512.1 K to 522.1 K (+1.95 %) |
| Mar 08 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.26 | 606 | 160 | 29,697 | |
| Mar 08 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.26 | 9,394 | 2,480 | 0 | |
| Mar 08 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 16.15 | 10,000 | 161,463 | 713,510 | 723.5 K to 713.5 K (-1.38 %) |
| Mar 08 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.26 | 10,000 | 2,640 | 723,510 | 713.5 K to 723.5 K (+1.40 %) |
| Feb 22 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.26 | 10,000 | 2,640 | 12,424 | |
| Feb 22 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 14.79 | 10,000 | 147,872 | 512,143 | 522.1 K to 512.1 K (-1.92 %) |
| Feb 22 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.26 | 10,000 | 2,640 | 522,143 | 512.1 K to 522.1 K (+1.95 %) |
| Feb 08 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.26 | 10,000 | 2,640 | 9,394 | |
| Feb 08 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 12.50 | 10,000 | 125,048 | 713,510 | 723.5 K to 713.5 K (-1.38 %) |
| Feb 08 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.26 | 10,000 | 2,640 | 723,510 | 713.5 K to 723.5 K (+1.40 %) |
| Jan 25 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 10.45 | 200,000 | 2,090,000 | 200,000 | |
| Jan 25 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 10.45 | 200,000 | 2,090,000 | 200,000 | |
| Jan 22 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.26 | 10,000 | 2,640 | 22,424 | |
| Jan 22 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 10.09 | 10,000 | 100,882 | 512,143 | 522.1 K to 512.1 K (-1.92 %) |
| Jan 22 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.26 | 10,000 | 2,640 | 522,143 | 512.1 K to 522.1 K (+1.95 %) |
| Jan 09 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.26 | 10,000 | 2,640 | 19,394 | |
| Jan 09 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 10.08 | 10,000 | 100,769 | 713,510 | 723.5 K to 713.5 K (-1.38 %) |
| Jan 09 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.26 | 10,000 | 2,640 | 723,510 | 713.5 K to 723.5 K (+1.40 %) |
| Dec 20 2017 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.26 | 10,000 | 2,640 | 32,424 | |
| Dec 20 2017 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 9.16 | 10,000 | 91,553 | 512,143 | 522.1 K to 512.1 K (-1.92 %) |
| Dec 20 2017 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.26 | 10,000 | 2,640 | 522,143 | 512.1 K to 522.1 K (+1.95 %) |
| Dec 08 2017 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.26 | 10,000 | 2,640 | 29,394 | |
| Dec 08 2017 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 10.39 | 10,000 | 103,903 | 713,510 | 723.5 K to 713.5 K (-1.38 %) |
| Dec 08 2017 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.26 | 10,000 | 2,640 | 723,510 | 713.5 K to 723.5 K (+1.40 %) |
| Jun 15 2017 | VSTM | Verastem, Inc. | Kauffman Michael | Director | Option Exercise | A | 2.09 | 25,000 | 52,250 | 25,000 | |
| Apr 06 2017 | INFI | INFINITY PHARMACEU ... | Kauffman Michael | Director | Option Exercise | A | 2.80 | 40,000 | 112,000 | 40,000 | |
| Jan 24 2017 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 10.39 | 250,000 | 2,597,500 | 250,000 | |
| Jan 24 2017 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 10.39 | 250,000 | 2,597,500 | 250,000 | |
| Jun 16 2016 | VSTM | Verastem, Inc. | Kauffman Michael | Director | Option Exercise | A | 1.37 | 25,000 | 34,250 | 25,000 | |
| Feb 17 2016 | VSTM | Verastem, Inc. | Kauffman Michael | Director | Sell | S | 6.46 | 2,070 | 13,374 | 0 | 2.1 K to 0 (-100.00 %) |
| Feb 17 2016 | VSTM | Verastem, Inc. | Kauffman Michael | Director | Sell | S | 10.96 | 930 | 10,192 | 2,070 | 3 K to 2.1 K (-31.00 %) |
| Jan 20 2016 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 6.54 | 170,000 | 1,111,800 | 170,000 | |
| Jan 20 2016 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 6.54 | 170,000 | 1,111,800 | 170,000 | |
| Jun 16 2015 | VSTM | Verastem, Inc. | Kauffman Michael | Director | Option Exercise | A | 7.99 | 17,969 | 143,572 | 17,969 | |
| Jun 05 2006 | CRXX | EPIRUS Biopharmace ... | Kauffman Michael | Director | Option Exercise | A | 8.29 | 22,857 | 189,485 | 22,857 |